KORTHOS / ECOSYSTEM / PRODUCT

Hugo RAS System

About

About Hugo RAS System

Hugo RAS is Medtronic’s modular robotic-assisted surgery system for adult minimally invasive urologic procedures. Separate arm carts can be positioned in different configurations around the patient, while an open surgeon console provides a three-dimensional view and maintains sightlines to the bedside team.

The system tower links the console and arm carts with KARL STORZ imaging and the Valleylab FT10 energy platform. Its endoscope can be placed on any robotic arm, and the architecture supports multi-quadrant access with adjustable arm height and tilt. Touch Surgery services add training, tele-proctoring and post-case insights. The system received US FDA clearance for urologic surgical procedures in December 2025.

Timeline

  • Medtronic adds FDA-cleared LigaSure vessel sealer to Hugo

    2026-09-16 - Regulatory - The instrument seals and cuts vessels, thick tissue and lymphatics up to 7 mm in diameter and is designed for the Valleylab FT10 energy platform. Hugo is currently cleared for urologic procedures in the United States; Medtronic is pursuing broader soft-tissue indications. The LigaSure RAS Maryland instrument had been introduced on Hugo in Europe in 2025 after CE marking.

    Source
  • Medtronic and Asan Medical Center partner on Hugo robotic surgery

    2026-05-20 - Partnership - The collaboration covers clinical research, education and technology development around Hugo RAS. The agreement followed Hugo regulatory approvals in Europe, Japan, Korea and the U.S.

    Source
  • Medtronic receives FDA clearance for Hugo robotic-assisted surgery system

    2025-12-03 - Regulatory - Medtronic received U.S. FDA clearance for the Hugo robotic-assisted surgery system for urologic procedures. The clearance was supported by the Expand URO clinical study in multi-port robotic-assisted urological surgery. The decision brings Hugo into the U.S. soft-tissue robotic surgery market alongside Medtronic's broader surgical portfolio.

    Source
  • Medtronic Expand URO trial meets Hugo RAS safety and effectiveness endpoints

    2025-04-26 - Market Signal - Medtronic announced that its Expand URO U.S. clinical trial for the Hugo RAS system met primary safety and effectiveness endpoints. The study evaluated Hugo RAS for urologic surgical procedures in the United States. Medtronic said the results supported its submission pathway for Hugo RAS in urology.

    Source

Context

Comparable Systems